Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study

被引:3
|
作者
Gulpen, Anouk J. W. [1 ,2 ,3 ]
Braeken, Dionne C. W. [1 ]
Schalla, Simon [2 ,4 ]
Ten Cate, Hugo [1 ,2 ,3 ]
Crijns, Harry J. [2 ,4 ]
Ten Cate-Hoek, Arina J. [1 ,2 ]
机构
[1] Maastricht & Lab Clin Thrombosis & Hemostasis, Thrombosis Expert Ctr, Maastricht, Netherlands
[2] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[3] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Ctr, Dept Cardiol & Radiol, Maastricht, Netherlands
关键词
Direct oral anticoagulants; Thrombosis; Adherence; WARFARIN; DABIGATRAN; PERSISTENCE; APIXABAN; THERAPY; SCALE;
D O I
10.1159/000524094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term treatment with direct oral anticoagulants (DOAC) is required for the majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and systemic embolism. Adherence to therapy may impact clinical outcomes. Therefore, the purpose of this study was to assess the potential impact of structured follow-up on long-term adherence to DOAC therapy compared to standard care. Methods: This is a cross sectional study on the implementation phase of medication adherence to DOACs, comparing patients with AF following completion of structured follow-up of minimally 1 year with those who received standard care. All patients used DOACs for more than 2 years and completed a questionnaire on adherence. Adherence was measured with the Morisky Medication Adherence Scale-8 (MMAS-8) score and assessed via an online web portal. Results: A total of 212 patients were included. The mean MMAS-8 score was 7.55 (SD 0.93) after structured follow-up and 7.25 (SD 1.01) for standard care; p = 0.045. Following structured follow-up 64.1% of patients had a high adherence (MMAS score of 8) compared to 50% receiving standard care; p = 0.05. Patients following structured follow-up on a once daily DOAC regime had higher MMAS-8 scores compared to those on a twice daily regime; 7.74 (SD 0.74) versus 7.00 (SD 1.22); p < 0.001. The rates of minor bleedings were 10.6% versus 21.4% respectively, p = 0.038. Conclusion: In patients on long-term DOAC treatment, adherence to therapy was significantly increased after receiving an initial period of structured follow-up compared to standard care. Additionally, adherence to DOAC therapy was higher with once-daily treatment regimen. Significant more minor bleedings were reported in the standard care group. These results indicate that implementation of structured follow-up of patients with AF using DOACs merits further evaluation. (c) 2022 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:476 / 483
页数:8
相关论文
共 50 条
  • [41] Mental health conditions and adherence to direct oral anticoagulants in patients with incident atrial fibrillation: A nationwide cohort study
    Teppo, Konsta
    Jaakkola, Jussi
    Airaksinen, K. E. Juhani
    Airaksinen, Juhani
    Biancari, Fausto
    Halminen, Olli
    Putaala, Jukka
    Mustonen, Pirjo
    Haukka, Jari
    Hartikainen, Juha
    Luojus, Alex
    Niemi, Mikko
    Linna, Miika
    Lehto, Mika
    GENERAL HOSPITAL PSYCHIATRY, 2022, 74 : 88 - 93
  • [42] The treatment pattern and adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65
    Han, Sola
    Jeong, Hwa Seop
    Kim, Hyungtae
    Suh, Hae Sun
    PLOS ONE, 2019, 14 (04):
  • [43] Characterization of long-term oral anticoagulant adherence trajectories among patients with atrial fibrillation: a retrospective observational study
    Salmasi, S.
    Safari, A.
    De Vera, M.
    Lynd, L.
    Koehoorn, M.
    Barry, A. R.
    Andrade, J. G.
    Deyell, M. W.
    Rush, K.
    Zhao, Y.
    Loewen, P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 564 - 564
  • [44] LONG-TERM OUTCOME IN STROKE PATIENTS WITH ATRIAL FIBRILLATION IN THE ERA OF DIRECT ORAL ANTICOAGULANT
    Nagakane, Y.
    Tanaka, E.
    Yamada, T.
    Hamanaka, M.
    Fujinami, J.
    Ashida, S.
    Kojima, Y.
    Maezono-Kandori, K.
    Ogura, S.
    Yamamoto, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 316 - 316
  • [45] Comparative effectiveness and safety of direct oral anticoagulants and warfarin in atrial fibrillation patients with dementia
    Fang, Chen-Wen
    Hsieh, Cheng-Yang
    Yang, Hsin-Yi
    Tsai, Ching-Fang
    Sung, Sheng-Feng
    EUROPEAN STROKE JOURNAL, 2024,
  • [46] IS A CONTROLLED TRIAL OF LONG-TERM ORAL ANTICOAGULANTS IN PATIENTS WITH STROKE AND NONRHEUMATIC ATRIAL-FIBRILLATION WORTHWHILE
    SANDERCOCK, P
    WARLOW, C
    BAMFORD, J
    PETO, R
    STARKEY, I
    LANCET, 1986, 1 (8484): : 788 - 792
  • [47] Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
    Grymonprez, Maxim
    Capiau, Andreas
    Steurbaut, Stephane
    Mehuys, Els
    Boussery, Koen
    De Backer, Tine L.
    Lahousse, Lies
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [48] ADHERENCE TO ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS OF A MULTI-COUNTRY STUDY
    Mueller, S.
    Meinecke, A. K.
    Buchwald, S.
    Eriksson, D.
    Wilke, T.
    VALUE IN HEALTH, 2019, 22 : S567 - S567
  • [49] Patient safety and estimation of renal in function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study
    MacCallum, Peter K.
    Mathur, Rohini
    Hull, Sally A.
    Saja, Khalid
    Green, Laura
    Morris, Joan K.
    Ashman, Neil
    BMJ OPEN, 2013, 3 (09):
  • [50] Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross‐sectional study
    Frederico Bartolazzi
    Antônio Luiz Pinho Ribeiro
    Waleska Jaclyn Freitas Nunes de Sousa
    Mayara Sousa Vianna
    José Luiz Padilha da Silva
    Maria Auxiliadora Parreiras Martins
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 1074 - 1080